Concepedia

Mathilde Bernardin

MB

Statistics

Publications

2

Citations

112

H-Index

2

Active since

2012

Affiliations

Université Claude Bernard Lyon 1(Current)

Mathilde Bernardin is an author at Université Claude Bernard Lyon 1 specializing in medicine, small molecule tyrosine kinase inhibitors, and cytotoxic chemotherapy.

Publications per year

2012–2019

2

Publications

2

Pain assessment in Charcot-Marie-Tooth (CMT) disease

Catherine Ribière, Mathilde Bernardin, Sabrina Sacconi et al. · Annals of Physical and Rehabilitation Medicine · 2012 · 64 citations

, , +9

MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).

Philippe A. Cassier, Gwenaëlle Garin, Lauriane Eberst et al. · Journal of Clinical Oncology · 2019 · 48 citations

, , +17

1–2 of 2